Sign inJoin waitlistJoin the waitlist

JG

John Greer

Hematology

Credentials: ·

Research

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
The Lancet Oncology · 2018 · 552 citations
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia
Journal of Clinical Oncology · 1993 · 310 citations
Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma
Journal of Clinical Oncology · 1991 · First of 8 authors · 211 citations

SG
Stacey Goodman
34 papers
RS
Richard Stein
30 papers
Madan Jagasia
28 papers
SW
Steven Wolff
27 papers
BS
Bipin Savani
22 papers
BE
Brian Engelhardt
22 papers · 2 as a fellow
DM
David Morgan
22 papers
Adetola Kassim
21 papers
JF
John Flexner
17 papers
RC
Robert Collins
16 papers · 1 as a fellow
WC
Wichai Chinratanalab
16 papers
Marsha Kinney
13 papers · 2 as a fellow